Vivos Inc.
Moat Score — Vivos Inc.
Total Moat Score
7 / 30
| Moat Factor | Score | Analysis |
|---|---|---|
| Intangible Assets Patents, trademarks, brand strength, or regulatory licenses that protect a company's products or services from being freely copied by competitors. | 3 / 5 | Vivos's RadioGel/IsoPet technology — a proprietary Y-90-loaded gel that stays liquid at room temperature and sets at body temperature inside a tumor — is a genuinely novel delivery mechanism that earned FDA Breakthrough Device designation for a thyroid cancer indication, though it remains unapproved for human use. |
| Cost Advantage A durable ability to produce goods or services more cheaply than competitors — through scale, unique access to cheap inputs, location, or process — that lets a company undercut rivals or out-earn them at the same price. | 0 / 5 | With only $27,995 in 2024 revenue and a single full-time employee, Vivos has no scale or cost advantage of any kind; it is an early-stage, asset-light company dependent on outsourced manufacturing. |
| Pricing Power The ability to raise prices without losing meaningful business, because the product or service is differentiated, mission-critical, or has few good substitutes. | 1 / 5 | Veterinary clinic certification fees and product sales are only beginning to ramp (4 to 13 certified clinics from 2023 to 2024), too early to demonstrate real pricing power, and any future human-therapy pricing power is entirely contingent on an approval that has not yet occurred. |
| Network Effect The product or service becomes more valuable to every user as more people or organizations use it, making an established leader harder to displace. | 1 / 5 | A growing network of certified veterinary clinics creates a mild network-like dynamic — more certified clinics mean more referring veterinarians and easier access for pet owners — but the scale (13 clinics) is far too small yet to constitute a real moat. |
| Switching Costs The money, time, or operational disruption a customer would face switching to a competitor, which locks in existing customers and supports renewals. | 1 / 5 | Once a veterinary clinic invests time and training to become IsoPet-certified, there is some switching cost to adopting a different radiotherapy approach, but the overall clinic network remains small enough that this is a minor factor today. |
| Efficient Scale A market that can only profitably support a small number of players, so incumbents face limited threat from new entrants even without other defenses. | 1 / 5 | The veterinary radiation-oncology niche Vivos serves is small and specialized enough to discourage large competitors from entering purely for that market, but it is also too small to generate meaningful revenue on its own absent human-indication approval. |